These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25086936)
1. Quantification of hepatic fat and iron with magnetic resonance imaging. Wells SA Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):397-416. PubMed ID: 25086936 [TBL] [Abstract][Full Text] [Related]
2. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008 [TBL] [Abstract][Full Text] [Related]
3. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538 [TBL] [Abstract][Full Text] [Related]
4. Fat and iron quantification in the liver: past, present, and future. Yokoo T; Browning JD Top Magn Reson Imaging; 2014 Apr; 23(2):73-94. PubMed ID: 24690618 [TBL] [Abstract][Full Text] [Related]
5. Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Bashir MR; Merkle EM; Smith AD; Boll DT Eur J Radiol; 2012 Feb; 81(2):e101-9. PubMed ID: 21330083 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the pediatric liver: imaging of steatosis, iron deposition, and fibrosis. Towbin AJ; Serai SD; Podberesky DJ Magn Reson Imaging Clin N Am; 2013 Nov; 21(4):669-80. PubMed ID: 24183519 [TBL] [Abstract][Full Text] [Related]
7. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique. Boll DT; Marin D; Redmon GM; Zink SI; Merkle EM AJR Am J Roentgenol; 2010 Apr; 194(4):964-71. PubMed ID: 20308498 [TBL] [Abstract][Full Text] [Related]
8. Validation of MRI biomarkers of hepatic steatosis in the presence of iron overload in the ob/ob mouse. Hines CD; Agni R; Roen C; Rowland I; Hernando D; Bultman E; Horng D; Yu H; Shimakawa A; Brittain JH; Reeder SB J Magn Reson Imaging; 2012 Apr; 35(4):844-51. PubMed ID: 22127834 [TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293 [TBL] [Abstract][Full Text] [Related]
10. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy. Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490 [TBL] [Abstract][Full Text] [Related]
11. MR imaging of diffuse liver disease. Hepatic fat and iron. Siegelman ES Magn Reson Imaging Clin N Am; 1997 May; 5(2):347-65. PubMed ID: 9113679 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740 [TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis]. Van Beers B Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953 [TBL] [Abstract][Full Text] [Related]
16. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy. Boudinaud C; Abergel A; Joubert-Zakeyh J; Fontarensky M; Pereira B; Chauveau B; Garcier JM; Chabrot P; Boyer L; Magnin B Eur J Radiol; 2019 Sep; 118():169-174. PubMed ID: 31439237 [TBL] [Abstract][Full Text] [Related]
17. Quantification of macrovesicular and microvesicular hepatic steatosis in rats using 3.0-T ¹H-magnetic resonance spectroscopy. Ou HY; Chao PH; Yu PC; Wei YC; Chen CL; Yu CY; Chiu TM; Chang YC; Lai CY; Cheng YF Transplant Proc; 2012 May; 44(4):955-8. PubMed ID: 22564595 [TBL] [Abstract][Full Text] [Related]
18. Different forms of iron accumulation in the liver on MRI. İdilman İS; Akata D; Özmen MN; Karçaaltıncaba M Diagn Interv Radiol; 2016; 22(1):22-8. PubMed ID: 26712679 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences. Plaikner M; Kremser C; Zoller H; Jaschke W; Steurer M; Viveiros A; Henninger B Eur Radiol; 2020 Nov; 30(11):5826-5833. PubMed ID: 32535737 [TBL] [Abstract][Full Text] [Related]
20. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model. van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]